Psomagen, Inc. (KOSDAQ:950200)
South Korea · Delayed Price · Currency is KRW 2,970.00
+40.00 (1.37%)
At close: Oct 16, 2026
Psomagen Market Cap
Psomagen has a market cap or net worth of 57.13 billion as of October 16, 2026. It is the 31,541st most valuable company in the world and the 1,720th biggest in South Korea. Its market cap has decreased by 19.40% in one year.
Market Cap
57.13B
Enterprise Value
56.08B
Revenue
60.70B
Global Rank
Country Rank
#1,720 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 13, 2020, Psomagen's market cap has decreased from 254.61B to 57.13B, a decrease of -77.56%. That is a compound annual growth rate of -21.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 57.13B | -23.45% |
| Dec 30, 2025 | 74.64B | -4.20% |
| Dec 30, 2024 | 77.91B | -20.59% |
| Dec 28, 2023 | 98.10B | -34.17% |
| Dec 29, 2022 | 149.03B | -12.38% |
| Dec 30, 2021 | 170.10B | -50.35% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Naturalendo Tech | 68.20B |
| IMGT Co.,Ltd. | 67.28B |
| SunBio,Inc. | 66.57B |
| PanGen Biotech | 64.26B |
| ABION | 60.91B |
| ADBiotech | 58.08B |
| TegoScience | 55.09B |
| NovMetaPharma | 54.06B |